A detailed history of Parker Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Parker Financial LLC holds 1,424 shares of ABBV stock, worth $275,572. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,424
Previous 1,375 3.56%
Holding current value
$275,572
Previous $250 Million 2.45%
% of portfolio
0.13%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $7,584 - $8,857
49 Added 3.56%
1,424 $244 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $19,338 - $22,034
-121 Reduced 8.09%
1,375 $250 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $275 - $309
2 Added 0.13%
1,496 $232 Million
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $133,590 - $154,650
-1,000 Reduced 40.1%
1,494 $223 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $330,479 - $411,260
2,494 New
2,494 $336 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $186,165 - $223,261
1,346 New
1,346 $218 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parker Financial LLC Portfolio

Follow Parker Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parker Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parker Financial LLC with notifications on news.